Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Recent patent covers new PDE5 inhibitors designed at Lilly Icos

June 21, 2002

Trospium completes phase III trial in overactive bladder

June 20, 2002

Senju patents novel Na+/Ca2+ exchange inhibitors

June 19, 2002

Boehringer Ingelheim claims new agents for urinary incontinence

June 18, 2002

Shire files for approval of Fosrenol in Canada

June 11, 2002

Nasal apomorphine set to enter phase I trials for erectile dysfunction

June 7, 2002

IPD-1151T may be preferable to other drugs in the treatment of interstitial cystitis

June 6, 2002

A possible role for the nicotinic agonist epibatidine in neurogenic voiding dysfunction

June 6, 2002

KW-7158 depresses bladder hyperactivity through afferent pathways

June 6, 2002

Lilly Icos presents novel phosphodiesterase inhibitors

June 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...